Showing 91-100 of 100 results for "".
- AVAVA Receives FDA Clearance for Acne Scar Treatment on All Skin Types Using Focal Point Technologyhttps://modernaesthetics.com/news/avava-receives-fda-clearance-for-acne-scar-treatment-on-all-skin-types-using-focal-point-technology/2475350/The U.S. Food and Drug Administration (FDA) has cleared AVAVA’s Focal Point Technology™ for the treatment of acne scars, marking a significant milestone in energy-based skin therapy. The technology, developed by Boston-based AVAVA, is now indicated for acne scarring in all Fitzpatrick skin types
- DefenAge 360-Rejuvenation Nail Root Serum Earns Allure Awardhttps://modernaesthetics.com/news/defenage-360-rejuvenation-nail-root-serum-earns-allure-award/2473680/DefenAge® Skincare’s 360-Rejuvenation Nail Root Serum earned a 2024 Allure Best of Beauty Award, DefenAge announced. “This recognition marks a significant milestone for the brand,” the company said in a press release, “solidifying its commitment to delivering
- Evolus to Ring Nasdaq Stock Market Closing Bell On September 13https://modernaesthetics.com/news/evolus-to-ring-nasdaq-stock-market-closing-bell-on-september-13/2473667/Evolus Inc. announced the company will be ringing the Nasdaq closing bell on Friday, September 13. The Nasdaq closing bell ceremony is a time-honored tradition, serving as a platform for companies to celebrate achievements and milestones. “We are honored to h
- Letybo (letibotulinumtoxinA-wlbg) Receives FDA Approvalhttps://modernaesthetics.com/news/fda-grants-approval-for-letybo-letibotulinumtoxina-wlbg/2473551/Hugel America, Inc., announced the achievement of a significant milestone with the U.S. Food and Drug Administration (FDA) granting approval for its neurotoxin, Letybo. "We are thrilled with the FDA's approval of Letybo. This is a huge achievement for Hugel as we
- R2 Technologies Ships 100 GLACIAL Deviceshttps://modernaesthetics.com/news/r2-technologies-ships-100-glacial-devices/2473224/R2 Technologies Inc. has shipped 100 GLACIAL Rx devices across the globe. To-date customers have delivered more than 15,000 GLACIAL treatment cycles, helping patients reach their skin goals by reducing inflammation and revealing younger looking skin. R2 reached this mileston
- Galderma's Restylane Turns 25!https://modernaesthetics.com/news/galdermas-restylane-turns-25/2473147/Galderma’s Restylane is celebrating 25 years on the market. Since launching in Europe in 1996, Restylane has celebrated many milestones across the globe. This includes the first approval for use by the U.S. Food and Drug Administration (FDA) in 2003 and in China by the Nation
- Galderma's Dysport Celebrates 10 Years Since FDA Approvalhttps://modernaesthetics.com/news/dysport-celebrates-10-years-since-fda-approval/2471921/Galderma Laboratories’ Dysport (abobotulinumtoxinA) is ringing in its 10th birthday. To celebrate this milestone, Galderma is offering double points for Dysport aesthetic treatments registered in
- Galderma's ASPIRE Rewards Program Hits the Million Member Markhttps://modernaesthetics.com/news/galdermas-aspire-rewards-program-hits-the-million-member-mark/2472003/Galderma Laboratories, L.P’s ASPIRE Rewards program has reached the one million member milestone. ASPIRE is a loyalty program for consumers and aesthetic providers who use Galderma aesthetic injectab
- Cutera Marks 20 Years of Innovationhttps://modernaesthetics.com/news/cuter-marks-20-years-of-innovation/2472102/Cutera, Inc. is celebrating 20 years of best-in-class product innovation with continued commitment to the industry and its providers, marking the milestone at the Annual Meeting of the American Society for Laser Medicine and Surgery in Dallas. In conjunction with the 20th&nbs
- Miles Harrisonhttps://modernaesthetics.com/profiles/miles-harrison/OWGpGo/
- Previous
- Next